PROCEPT BioRobotics reported revenue of $94.50M and net income of -$26.86M for the quarter ended Jun 2026, up 19.3% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||
| Revenue | 8.67M | 10.14M | 14.20M | 16.69M | 20.35M | 23.78M | 24.40M | 33.10M | 35.10M | 43.58M | 44.54M | 53.35M | 58.37M | 68.24M | 69.16M | 79.18M | 83.33M | 76.38M | 83.13M | 94.50M | ||||
| Cost of RevenueCost of Rev | 4.43M | 5.62M | 6.50M | 8.21M | 10.12M | 13.10M | 11.91M | 14.68M | 16.23M | 22.33M | 19.50M | 21.87M | 21.46M | 24.56M | 25.00M | 27.44M | 29.32M | 30.07M | 29.18M | 32.12M | ||||
| Gross Profit | 4.24M | 4.52M | 7.69M | 8.49M | 10.23M | 10.68M | 12.49M | 18.43M | 18.87M | 21.25M | 25.03M | 31.48M | 36.91M | 43.67M | 44.16M | 51.75M | 54.01M | 46.31M | 53.95M | 62.38M | ||||
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 4.92M | 5.08M | 5.01M | 6.71M | 7.58M | 9.68M | 10.74M | 11.61M | 11.60M | 14.50M | 13.08M | 17.50M | 16.65M | 15.07M | 16.40M | 17.63M | 18.19M | 19.06M | 21.46M | 20.10M | ||||
| Selling, General & AdministrativeSG&A | 12.12M | 16.27M | 18.39M | 19.66M | 24.75M | 26.03M | 30.13M | 32.44M | 32.88M | 36.32M | 39.60M | 40.81M | 42.69M | 48.32M | 55.20M | 56.30M | 59.01M | 58.30M | 65.09M | 69.67M | ||||
| Operating ExpensesOpex | 17.04M | 21.35M | 23.40M | 26.36M | 32.34M | 35.72M | 40.87M | 44.05M | 44.48M | 50.81M | 52.68M | 58.31M | 59.34M | 63.38M | 71.60M | 73.94M | 77.20M | 77.35M | 86.55M | 89.77M | ||||
| Operating IncomeOp. Inc | -12.80M | -16.83M | -15.70M | -17.88M | -22.11M | -25.04M | -28.38M | -25.62M | -25.61M | -29.56M | -27.65M | -26.83M | -22.43M | -19.71M | -27.44M | -22.19M | -23.19M | -31.04M | -32.61M | -27.39M | ||||
| EBIT | -12.80M | -16.83M | -15.70M | -17.88M | -22.11M | -25.04M | -28.38M | -25.62M | -25.61M | -29.56M | -27.65M | -26.83M | -22.43M | -19.71M | -27.44M | -22.19M | -23.19M | -31.04M | -32.61M | -27.39M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.47M | 1.44M | 1.42M | 1.44M | 1.46M | 0.87M | 0.89M | 0.96M | 1.02M | 1.12M | 1.04M | 1.03M | 1.14M | 0.97M | 0.88M | 0.90M | 0.92M | 0.89M | 0.82M | 0.84M | ||||
| Non Operating IncomeNon Op. Inc. | 0.16M | -0.08M | -0.06M | 0.13M | 0.95M | 0.99M | 0.78M | 1.30M | 2.01M | 3.26M | 2.74M | 2.23M | 2.59M | 2.19M | 3.53M | 3.64M | 2.70M | 2.28M | 1.74M | 1.47M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | -14.27M | -18.27M | -17.12M | -19.32M | -23.56M | -25.91M | -29.26M | -26.59M | -26.63M | -30.68M | -28.69M | -27.86M | -23.57M | -20.68M | -24.78M | -19.44M | -24.11M | -31.93M | -31.68M | -26.77M | ||||
| Tax ProvisionsTaxes | -0.05M | 0.14M | -0.04M | 0.09M | ||||||||||||||||||||
| Profit After TaxPAT | -14.11M | -18.36M | -17.18M | -19.18M | -22.61M | -28.17M | -28.48M | -25.29M | -24.62M | -27.50M | -25.96M | -25.63M | -20.99M | -18.75M | -24.74M | -19.95M | -21.41M | -29.85M | -31.64M | -26.86M | ||||
| Income from Continuing OperationsIncome (Continuing) | -14.27M | -18.27M | -17.12M | -19.32M | -23.56M | -25.91M | -29.26M | -26.59M | -26.63M | -30.68M | -28.69M | -27.86M | -23.57M | -20.68M | -24.74M | -19.58M | -24.11M | -31.93M | -31.64M | -26.86M | ||||
| Consolidated Net IncomeConsol Net Inc. | -14.27M | -18.27M | -17.12M | -19.32M | -23.56M | -25.91M | -29.26M | -26.59M | -26.63M | -30.68M | -28.69M | -27.86M | -23.57M | -20.68M | -24.74M | -19.58M | -24.11M | -31.93M | -31.64M | -26.86M | ||||
| Income towards Parent CompanyParent Net Inc | -14.27M | -18.27M | -17.12M | -19.32M | -23.56M | -25.91M | -29.26M | -26.59M | -26.63M | -30.68M | -28.69M | -27.86M | -23.57M | -20.68M | -24.74M | -19.58M | -24.11M | -31.93M | -31.64M | -26.86M | ||||
| Net Income towards Common StockholdersNet Income | -14.27M | -18.27M | -17.12M | -19.32M | -23.56M | -25.91M | -29.26M | -26.59M | -26.63M | -30.68M | -28.69M | -27.86M | -23.57M | -20.68M | -24.74M | -19.58M | -24.11M | -31.93M | -31.64M | -26.86M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -1.23 | -1.11 | -0.39 | -0.44 | -0.53 | -0.58 | -0.65 | -0.59 | -0.55 | -0.65 | -0.56 | -0.54 | -0.45 | -0.40 | -0.45 | -0.35 | -0.43 | -0.57 | -0.56 | -0.47 | ||||
| EPS (Diluted) | -1.23 | -1.11 | -0.39 | -0.44 | -0.53 | -0.58 | -0.65 | -0.59 | -0.55 | -0.65 | -0.56 | -0.54 | -0.45 | -0.40 | -0.45 | -0.35 | -0.43 | -0.57 | -0.56 | -0.47 | ||||
| Shares Outstanding | 11.58M | 16.48M | 43.85M | 44.32M | 44.64M | 44.40M | 45.07M | 45.16M | 48.31M | 47.26M | 51.01M | 51.62M | 52.01M | 52.12M | 54.92M | 55.45M | 55.73M | 55.54M | 56.51M | 57.07M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 11.58M | 16.48M | 43.85M | 44.32M | 44.64M | 44.40M | 45.07M | 45.16M | 48.31M | 47.26M | 51.01M | 51.62M | 52.01M | 52.12M | 54.92M | 55.45M | 55.73M | 55.54M | 56.51M | 57.07M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 11.58M | 16.48M | 44.08M | 44.54M | 44.71M | 44.83M | 45.01M | 45.27M | 50.47M | 50.77M | 51.39M | 51.90M | 52.15M | 54.72M | 55.28M | 55.58M | 55.87M | 56.32M | 56.90M | 57.25M | ||||
| EBITDA | -12.80M | -16.83M | -15.70M | -17.88M | -22.11M | -25.04M | -28.38M | -25.62M | -25.61M | -29.56M | -27.65M | -26.83M | -22.43M | -19.71M | -27.44M | -22.19M | -23.19M | -31.04M | -32.61M | -27.39M | ||||
| Interest ExpensesInt Expense | 1.47M | 1.44M | 1.42M | 1.44M | 1.46M | 0.87M | 0.89M | 0.96M | 1.02M | 1.12M | 1.04M | 1.03M | 1.14M | 0.97M | 0.88M | 0.90M | 0.92M | 0.89M | 0.82M | 0.84M | ||||
| Tax Rate | 0.19% | -0.70% | 0.14% | -0.35% |